This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Amgen Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Xianqing Shi: Innovator in Pharmaceutical Synthesis
Introduction
Xianqing Shi is a notable inventor based in Newbury Park, CA (US). He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of innovative compounds. With a total of 3 patents to his name, Shi continues to push the boundaries of medicinal chemistry.
Latest Patents
One of Xianqing Shi's latest patents is focused on the synthesis of omecamtiv mecarbil. This patent provides a detailed synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. This work is crucial for advancing therapeutic options in cardiovascular medicine.
Career Highlights
Xianqing Shi is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Amgen has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Xianqing Shi has collaborated with talented professionals, including Sebastien Caille and Kyle Quasdorf. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.
Conclusion
Xianqing Shi's contributions to pharmaceutical synthesis exemplify the impact of dedicated inventors in the medical field. His work continues to inspire advancements in drug development and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile